Alaska pharmacists: First responders to the pandemic in the last frontier

J Am Pharm Assoc (2003). 2021 Jan-Feb;61(1):e35-e38. doi: 10.1016/j.japh.2020.09.008. Epub 2020 Oct 6.

Abstract

Background: Pharmacists are among the nation's most accessible and underused health professionals. Within their scope of practice, pharmacists can prescribe and administer vaccines, conduct point-of-care testing, and address drug shortages through therapeutic substitutions.

Objectives: To better use pharmacists as first responders to coronavirus disease 2019 (COVID-19), we conducted a needs and capacity assessment to (1) determine individual commitment to provide COVID-19 testing and management services, (2) identify resources required to provide these services, and (3) help prioritize unmet community needs that could be addressed by pharmacists.

Methods: In March 2020, pharmacists and student pharmacists within the Alaska Pharmacist Association worked to tailor, administer, and evaluate results from a 10-question survey, including demographics (respondent name, ZIP Code, cell phone, and alternate e-mail). The survey was developed on the basis of published COVID-19 guidelines, Centers for Disease Control and Prevention COVID-19 screening and management guidelines, National Association of Boards of Pharmacy guidance, and joint policy recommendation from pharmacy organizations.

Results: Pharmacies are located in the areas of greatest COVID-19 need in Alaska. Pharmacists are willing and interested in providing support. Approximately 63% of the pharmacists who completed the survey indicated that they were interested in providing COVID-19 nasal testing, 60% were interested in conducting COVID-19 antibody testing, and 93% were interested in prescribing and administering immunizations for COVID-19, as available. When asked about resources needed to enable pharmacists to prescribe antiviral therapy, 37% of the pharmacists indicated they needed additional education or training, and 39% required access to technology to bill and document provided services.

Conclusion: The primary barrier to pharmacists augmenting the current COVID-19 response is an inability to cover the costs of providing these health services. Pharmacists in Alaska are ready to meet COVID-19-related clinical needs if public and private insurers and legislators can help address the barriers to service sustainability.

MeSH terms

  • Alaska
  • COVID-19 Testing
  • COVID-19 Vaccines / administration & dosage
  • COVID-19* / diagnosis
  • COVID-19* / therapy
  • Emergency Responders*
  • Humans
  • Pharmaceutical Services / economics
  • Pharmaceutical Services / organization & administration
  • Pharmacists / economics
  • Pharmacists / organization & administration*
  • Professional Role
  • Students, Pharmacy / statistics & numerical data*
  • Surveys and Questionnaires

Substances

  • COVID-19 Vaccines